Balyasny Asset Management’s Strata Critical Medical Inc SRTA Stock Holding History

Balyasny Asset Management’s Portfolio SRTA Stock Details SRTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$482K	Buy	+91,533	New	+$482K	﹤0.01%	2529
2025 Q4	–	Sell	-160,863	Closed	-$814K	–	3095
2025 Q3	$814K	Buy	+160,863	New	+$711K	﹤0.01%	2205
2025 Q1	–	Sell	-14,600	Closed	-$62K	–	2805
2024 Q4	$62K	Buy	+14,600	New	+$55.6K	﹤0.01%	2629
2022 Q4	–	Sell	-14,033	Closed	-$57K	–	2794
2022 Q3	$57K	Buy	+14,033	New	+$72.1K	﹤0.01%	2461
2022 Q2	–	Sell	-36,207	Closed	-$307K	–	2759
2022 Q1	$307K	Buy	+36,207	New	+$254K	﹤0.01%	1917

Other funds holding SRTA

Third Point New York $4.68B AUM 37.3% 1-Year Est. Return

NRCM

Northern Right Capital Management Darien, Connecticut $337M AUM 63.03% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AIC

AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

PLC

Pillsbury Lake Capital San Francisco, California $366M AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Balyasny Asset Management's SRTA Position: Q2 2026 in Review

Balyasny Asset Management opened a new position in Strata Critical Medical Inc (SRTA) in Q2 2026: 91,533 shares worth $482K. The stake represents ﹤0.01% of the portfolio and ranks #2529 among its holdings. This is a return to the name: Balyasny Asset Management previously reported a position in SRTA as recently as Q3 2025.

Balyasny Asset Management first reported a position in SRTA in Q1 2022 and has held it in 5 quarters since. The position peaked at $814K in Q3 2025. 139 funds tracked by Wall St. Rank hold SRTA as of Q2 2026.

Balyasny Asset Management held 91,533 shares of Strata Critical Medical Inc worth $482K as of Q2 2026.
Strata Critical Medical Inc was a new Balyasny Asset Management position in Q2 2026.
Strata Critical Medical Inc made up ﹤0.01% of Balyasny Asset Management's portfolio in Q2 2026, its #2529 holding.
Balyasny Asset Management first reported a position in Strata Critical Medical Inc in Q1 2022 and has held it in 5 quarters since.
Balyasny Asset Management's Strata Critical Medical Inc position peaked at $814K in Q3 2025.
139 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.